Keurig Green Mountain Inc. (GMCR) Financials Nov 20, 2014,
Keurig Green Mountain Inc. (GMCR) Financials Nov 20, 2014, 7:56 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Keurig Green Mountain Inc.
Fiscal year is October-September. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 786.14M 1.36B 2.65B 3.86B 4.36B
Cost of Goods Sold (COGS) incl. D&A 540.74M 946.18M 1.75B 2.63B 2.74B
COGS excluding D&A 517.44M 901.72M 1.63B 2.45B 2.51B
Depreciation & Amortization Expense 23.31M 44.46M 113.64M 181.65M 229.19M
Depreciation 17.99M 29.48M 72.3M 135.66M 183.81M
Amortization of Intangibles 5.32M 14.97M 41.34M 45.99M 45.38M
Gross Income 245.39M 410.6M 904.65M 1.22B 1.62B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 169.01M 253.11M 525.11M 654.51M 854.16M
Research & Development 6.1M 12.5M 17.7M 41.7M 57.7M
Other SG&A 162.91M 240.61M 507.41M 612.81M 796.46M
Other Operating Expense 0 0 0 0 0
Unusual Expense (16.5M) 18.71M 16.87M 6.3M (5.51M)
EBIT after Unusual Expense 16.5M (18.71M) (16.87M) (6.3M) 5.51M
Non Operating Income/Expense (162,000) (269,000) (2.26M) 35.17M (13.17M)
Non-Operating Interest Income 0 0 0 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 4.69M 5.29M 57.66M 22.98M 18.18M
Gross Interest Expense 5.29M 6.59M 60.26M 25.78M 24.28M
Interest Capitalized 600,000 1.3M 2.6M 2.8M 6.1M
Pretax Income 88.03M 133.21M 302.75M 576.14M 740.87M
Income Tax 33.59M 53.7M 101.7M 212.64M 256.77M
Income Tax - Current Domestic 30.87M 53.69M 89.16M 116.2M 249.94M
Income Tax - Current Foreign 837,000 6.94M 21.31M 26.86M 29.9M
Income Tax - Deferred Domestic 1.89M (6.93M) (5.09M) 74.04M (10.35M)
Income Tax - Deferred Foreign 0 0 (3.69M) (4.46M) (12.72M)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 54.44M 79.51M 201.05M 363.5M 484.1M
Minority Interest Expense 0 0 1.55M 872,000 871,000
Net Income 54.44M 79.51M 199.5M 362.63M 483.23M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 54.44M 79.51M 199.5M 362.63M 483.23M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 54.44M 79.51M 199.5M 362.63M 483.23M
EPS (Basic) 0.48 0.60 1.36 2.34 3.23
Basic Shares Outstanding 113.98M 131.53M 146.21M 154.93M 149.64M
EPS (Diluted) 0.45 0.58 1.31 2.28 3.16
Diluted Shares Outstanding 120.37M 137.83M 152.14M 159.08M 152.8M
EBITDA 99.69M 201.94M 493.18M 751.9M 995.9M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Why the Insider Trading Line Isn't Always Clear-Cut Insider trading is one of those buzzwords that conjures up images of Wall Street shenanigans and pricey legal battles. But believe it or not, trading on insider info isn’t always a one-way ticket to a federal prison. What determines its legality often hinges on how the information was obtained and used. It's a...
Continue Reading
Looking Back at Four Decades of Eye Care Excellence Sitting in the middle of Singapore, the National University Hospital's Ophthalmology Department has chalked up a solid 40 years serving up top-notch eye care. This ain't just about celebrating another year; it's about shaking things up with fresh approaches to treating tricky eye disorders. They're not resting on any...
Continue Reading
Riding the Wave of Profit in Micromobility Sometimes all you need is a quick jolt of genius to turn the wheels of fortune. Dott seems to have hit that sweet spot in Q3 of 2026. Deploying 45,000 new vehicles wasn’t just a logistical feat; it was a calculated bet that paid off handsomely, bolstering their business to soaring heights. Performance that Packs a Punch The Q3...
Continue Reading
China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...
Continue Reading
GoldMining Inc. Shows a Clear Green Streak Sometimes, you're caught off guard by a company's clear dedication to getting things right, and GoldMining Inc.'s latest sustainability report shows they're not just chasing fool's gold. They've laid out a solid roadmap. With the rollers they've got—swapping environmental chaos for responsible exploration—these guys have...
Continue Reading
Nothing beats the thrill of a live performance under a night sky, with the adrenaline of a Formula 1 race still in the air. On October 9, 2026, Mandopop superstar JJ Lin captivated the crowd at the Padang Stage of the Singapore Grand Prix, delivering not just a concert but a spectacle of international scale. Stage Spectacle with Precision JJ Lin took control like a...
Continue Reading
Stock Hit and Legal Drama Panic set in when Better Home & Finance Holding Company took a 28.5% nosedive after spilling some less-than-sweet news. Their promise of hitting a billion in monthly loans? Stuck in limbo as borrower trepidation reared its ugly head amidst rising rates. Investors felt the heat, watching shares skydive $12.17, landing them at a bruised $30.52. A...
Continue Reading
More Than a Quick Fix: ANCEL's Impact Ever been frustrated because your car just won't start? Happens to the best of us, especially when that cold snap hits or your vehicle's been lounging around too long. ANCEL's Super Starter devices—let's talk about 'em. They've been making a name for themselves in the starting game, and I'm not yanking your chain here. According to...
Continue Reading
Unicycive Therapeutics' Rough Ride In this wild market, sometimes even the most seasoned investors get blindsided. Unicycive Therapeutics (NASDAQ: UNC) shareholders are currently caught in a storm with their stock nose-diving by 39.1% on June 30, 2026. It's like being taken to the cleaners without the decency of a warning. Failed Expectations & FDA Blues Here's the...
Continue Reading
Tom Brady’s CardVault Hits Pittsburgh’s Historic Strip District Pittsburgh just got another feather in its cap with CardVault by Tom Brady marking its 20th store at The Terminal. As if this city needed more sports excitement! Pittsburgh, with its die-hard Steelers, Penguins, and Pirates fans, snags a premium spot for sports collectibles. A Prime Spot for Serious...
Continue Reading
Top 5 Most Recently Viewed Articles
NOVONIX Secures Conditional Commitment from the U.S. Department of Energy NOVONIX Limited, a prominent player in the battery materials and technology sector, has recently announced a significant step towards its future expansion. A conditional commitment for a loan of up to US$754.8 million has been made available through one of its wholly-owned subsidiaries based in the...
Continue Reading
Understanding the Aircraft Mounts Market The aircraft mounts market is making significant strides, currently valued at USD 886.5 million, and projected to soar to USD 1.9 billion by the year 2034. This impressive growth is primarily fueled by the expansion of the aviation industry and increasing demands for air travel. Key Drivers of Market Growth With the global middle...
Continue Reading
Nokia and Surge Unite for Enhanced Connectivity Nokia has embarked on an exciting journey with Surge, a prominent telecommunications provider, to improve internet accessibility across Indonesia. This collaboration marks a significant step toward delivering affordable high-speed internet services in regions that currently face connectivity challenges. The Shift to 5G Fixed...
Continue Reading
TrustCo Bank Corp NY’s Performance Analysis TrustCo Bank Corp NY (NASDAQ: TRST) has recently released a comprehensive overview of its financial performance for the first three quarters, comparing its key metrics against industry peers. This analysis covers several significant indicators such as the Efficiency Ratio, Common Equity Tier 1 Capital Ratio, Cost of Funds, and...
Continue Reading
Overview of European Residential REIT's Annual Results European Residential Real Estate Investment Trust (ERES) has released its results for the fiscal year ending December 31, 2024. This detailed report outlines the strategic measures taken throughout the year to enhance operational and financial performance. Key Events and Strategic Initiatives In a significant move,...
Continue Reading